Clinical Trials Directory

Trials / Completed

CompletedNCT03104101

Transcutaneous Posterior Tibial Nerve Electrostimulation With Low Dose Trospium Chloride in OAB in Females

Evaluation of Transcutaneous Posterior Tibial Nerve Electro Stimulation With or Without Low Dose Trospium Chloride in the Management of Overactive Bladder in Females

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Alexandria University · Academic / Other
Sex
Female
Age
20 Years – 80 Years
Healthy volunteers
Accepted

Summary

This study was done to verify whether the combination of transcutaneous posterior tibial nerve stimulation (TPTNS) with low dose trospium chloride in the treatment of females with overactive bladder (OAB) would be more effective than TPTNS alone after failure of behavioral therapy.

Detailed description

The investigators randomized 30 women with OAB, in two groups: G I (15 patients) received 30 minutes TPTNS, three times a week; GII (15 patients) received TPTNS plus Low dose trospium chloride (20 mg once daily); all for 8 weeks. Patients were evaluated using Overactive Bladder Symptom Score questionnaire (OABSS), Incontinence Impact Questionnaire-short form 7 (IIQ-7), 3 day voiding diary and urodynamics at weeks 0 and 8.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTTPTNS+Drugone tablet Trospium Chloride 20 mg once daily Plus TPTNS
DEVICETPTNSSurface adhesive electrodes placed on the skin above medial malleolus

Timeline

Start date
2014-11-01
Primary completion
2015-11-30
Completion
2016-03-05
First posted
2017-04-07
Last updated
2017-04-07

Source: ClinicalTrials.gov record NCT03104101. Inclusion in this directory is not an endorsement.